Table 1: Oncomir and Tumor Suppressor miRNA Profiles in Human Cancers

Human miRNA Involvement
Cancer Oncomir Suppressor miRNA Oncogene Target References
Oncoviral integration-induced
Lymphomaa) mir-1204 [166]
(PVT-1)
Erythroleukemiaa) miR-17-92 [165]
(Fli-3)
T-cell leukemia miR-106a c-myc [164]
(Kis2)
miR-19b-2
miR-92-2
miR-20b
B-cell leukemia miR-155 miR-17-92 [44]
(BIC) [142]
Non-oncoviral
Brain cancer miR-21 miR-181 [169]
miR-221 [135]
Breast cancer miR-125b [134]
miR-145
miR-21
miR-155
Chronic miR-15 BCL2 [120, 170]
lymphocytic miR-16 [119]
leukemia
Gastric cancer miR-34b miR-128b [171]
miR-34c miR-129
miR-128c miR-148
miR-106b [172]
miR-222
Colorectal miR-143 v-Ki-ras (KRAS) [43]
neoplasia miR-145 [173]
Pancreatic cancer miR-21 miR-375 [174]
miR-221
miR-222
miR-181a, b, d
miR-155 [145]
Hepatocellular miR-18 miR-199 [175]
carcinoma miR-224 miR-195
miR-200
miR-125
miR-101 v-fos [176]
Lung cancer miR-17-92 let-7 Ras [136]
let-7a [137]
[177]
[138]
Papillary miR-222 [130]
thyroid miR-146 [178]
carcinoma miR-181
Teasticular miR-372 [179]
germ cell miR-373
tumor
Ovarian cancer miR-21 [116]
miR-141
miR-200a, b, c
miR-203
miR-205
(In sera specimens)

Note:
a) mouse-model.